{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:44:31Z","timestamp":1770817471098,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":4090,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.jpainsymman.2008.06.002","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T05:11:44Z","timestamp":1219813904000},"page":"e5-e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Midazolam-Induced Extrapyramidal Side Effects"],"prefix":"10.1016","volume":"36","author":[{"given":"Eric E.","family":"Prommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpainsymman.2008.06.002_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpainsymman.2007.03.006","article-title":"Subcutaneous midazolam as a cause of extrapyramidal side effects in a patient with prostate cancer","volume":"34","author":"Brown","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.jpainsymman.2008.06.002_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1385\/NCC:3:2:146","article-title":"A reversible generalized movement disorder in critically ill children with cancer","volume":"3","author":"Khan","year":"2005","journal-title":"Neurocrit Care"},{"issue":"6","key":"10.1016\/j.jpainsymman.2008.06.002_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0952-8180(93)90068-P","article-title":"Midazolam-induced athetoid movements of the lower extremities during epidural anesthesia reversed by physostigmine","volume":"5","author":"Vorsanger","year":"1993","journal-title":"J\u00a0Clin Anesth"},{"issue":"3","key":"10.1016\/j.jpainsymman.2008.06.002_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1017\/S0265021507002578","article-title":"Acute myoclonus following spinal anaesthesia","volume":"25","author":"Alfa","year":"2008","journal-title":"Eur J Anaesthesiol"},{"issue":"2","key":"10.1016\/j.jpainsymman.2008.06.002_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0196-0644(98)70148-9","article-title":"Reversal of midazolam-induced laryngospasm with flumazenil","volume":"32","author":"Davis","year":"1998","journal-title":"Ann Emerg Med"},{"issue":"12","key":"10.1016\/j.jpainsymman.2008.06.002_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00003643-200112000-00002","article-title":"The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature","volume":"18","author":"Weinbroum","year":"2001","journal-title":"Eur J\u00a0Anaesthesiol"},{"issue":"2","key":"10.1016\/j.jpainsymman.2008.06.002_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00441-006-0284-3","article-title":"GABA(A) receptor diversity and pharmacology","volume":"326","author":"Mohler","year":"2006","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.jpainsymman.2008.06.002_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits","volume":"359","author":"Fritschy","year":"1995","journal-title":"J\u00a0Comp Neurol"},{"issue":"6","key":"10.1016\/j.jpainsymman.2008.06.002_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/mds.10426","article-title":"Flumazenil, a GABA antagonist, may improve features of Parkinson's disease","volume":"18","author":"Ondo","year":"2003","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.jpainsymman.2008.06.002_bib10","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/mds.21022","article-title":"Intravenous flumazenil for Parkinson's disease: a single dose, double blind, placebo controlled, cross-over trial","volume":"21","author":"Ondo","year":"2006","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jpainsymman.2008.06.002_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","article-title":"CNS 7056: a novel ultra-short-acting Benzodiazepine","volume":"107","author":"Kilpatrick","year":"2007","journal-title":"Anesthesiology"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392408004375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392408004375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:01:03Z","timestamp":1760130063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392408004375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0885392408004375"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.06.002","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midazolam-Induced Extrapyramidal Side Effects","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}